The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

CD36 is a scavenger receptor involved in lipid uptake and inflammation. Recently, non-cell-bound CD36 (sCD36) was identified in plasma and suggested to be a marker of lipid accumulation in the vessel wall. Marine n-3 polyunsaturated fatty acids (PUFA) may have cardioprotective effects. This study ev...

Full description

Bibliographic Details
Main Authors: Erik Berg Schmidt, Søren Lundbye-Christensen, Michael René Skjelbo Nielsen, Stine Krogh Venø, Aase Handberg
Format: Article
Language:English
Published: MDPI AG 2013-08-01
Series:Marine Drugs
Subjects:
n-3 PUFA
CD36
adipose tissue
cardiovascular disease
randomised controlled trial
Online Access:http://www.mdpi.com/1660-3397/11/9/3324

Internet

http://www.mdpi.com/1660-3397/11/9/3324

Similar Items